Angiotensin-(1–7) administration attenuates Alzheimer’s disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation
Authors:
- 1 March 2017
- journal article
- Published by Elsevier in Neuroscience
- Vol. 346, 267-277
Abstract
No abstract availableKeywords
Funding Information
- National Foundation of Natural Science of China (81170752)
- National Key Clinical Specialties Construction Program of China
This publication has 51 references indexed in Scilit:
- Hyperglycemia Increases the Production of Amyloid Beta‐Peptide Leading to Decreased Endothelial Tight JunctionCNS Neuroscience & Therapeutics, 2016
- Intracellular angiotensin (1–7) increases the inward calcium current in cardiomyocytes. On the role of PKA activationMolecular and Cellular Biochemistry, 2015
- The ACE2/Ang-(1–7)/Mas axis can inhibit hepatic insulin resistanceMolecular and Cellular Endocrinology, 2014
- Neuronal over-expression of ACE2 protects brain from ischemia-induced damageNeuropharmacology, 2014
- Molecular Linkages Between Diabetes and Alzheimer's Disease: Current Scenario and Future ProspectsCNS & Neurological Disorders - Drug Targets, 2014
- Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's DiseasePLOS ONE, 2012
- Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin DeficiencyDiabetes, 2006
- Risk of dementia in diabetes mellitus: a systematic reviewThe Lancet Neurology, 2006
- Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive FunctionArchives of Neurology, 2004
- A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9Circulation Research, 2000